We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+11.65%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$864B
AUM Growth
+$69.1B
Cap. Flow
-$8.04B
Cap. Flow %
-0.93%
Top 10 Hldgs %
26.18%
Holding
2,679
New
185
Increased
873
Reduced
1,330
Closed
90

Top Buys

Rank Stock Value
1
MTCH icon
Match Group
MTCH
+$3.17B
2
NKE icon
Nike
NKE
+$1.94B
3
BAC icon
Bank of America
BAC
+$1.84B
4
FDX icon
FedEx
FDX
+$1.78B
5
PNC icon
PNC Financial Services
PNC
+$1.61B

Top Sells

Rank Stock Value
1
PPLI
People Inc
PPLI
+$4.1B
2
FTV icon
Fortive
FTV
+$2.54B
3
LIN icon
Linde
LIN
+$1.53B
4
BABA icon
Alibaba
BABA
+$1.35B
5
WTW icon
Willis Towers Watson
WTW
+$1.13B

Sector Composition

Rank Sector Weight
1 Technology 25.61%
2 Healthcare 16.74%
3 Consumer Discretionary 15.8%
4 Financials 11.46%
5 Communication Services 10.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSO icon
676
Watsco Inc
WSO
$12.9B
$91.8M 0.01%
394,002
-8,637
-2% -$1.95M
SUM
677
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$91.6M 0.01%
5,634,836
+1,106,377
+24% +$17.7M
EBS icon
678
Emergent Biosolutions
EBS
$230M
$91.5M 0.01%
885,771
+11,369
+1% +$1.23M
COKE icon
679
Coca-Cola Consolidated
COKE
$12.7B
$91.4M 0.01%
3,797,680
+111,950
+3% +$2.81M
BECN
680
DELISTED
Beacon Roofing Supply, Inc.
BECN
$91.3M 0.01%
2,937,612
+166,271
+6% +$5.01M
WHD icon
681
Cactus
WHD
$5.78B
$90.8M 0.01%
4,731,925
+905,392
+24% +$19.6M
ATRI
682
DELISTED
Atrion Corp
ATRI
$90.7M 0.01%
144,826
-136
-0.1% -$87.7K
ILMN icon
683
Illumina
ILMN
$29.1B
$90.6M 0.01%
301,309
-13,921
-4% -$4.8M
VC icon
684
Visteon
VC
$2.86B
$90.5M 0.01%
1,306,861
-2,705,557
-67% -$200M
CACI icon
685
CACI
CACI
$14.8B
$90.3M 0.01%
423,855
+14,997
+4% +$3.24M
MGY icon
686
Magnolia Oil & Gas
MGY
$6.13B
$89.9M 0.01%
17,394,760
+559,200
+3% +$3.48M
APLS
687
DELISTED
Apellis Pharmaceuticals
APLS
$89.9M 0.01%
2,978,400
-49,435
-2% -$1.48M
RETA
688
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$89.6M 0.01%
919,926
-9,396
-1% -$1.17M
PEGA icon
689
Pegasystems
PEGA
$5.51B
$88.6M 0.01%
1,463,304
-146,716
-9% -$8.44M
ATRC icon
690
AtriCure
ATRC
$2.21B
$88.5M 0.01%
2,217,639
-11,207
-0.5% -$475K
MEDP icon
691
Medpace
MEDP
$16.2B
$88M 0.01%
787,298
+3,525
+0.4% +$408K
MGEE icon
692
MGE Energy Inc
MGEE
$3.06B
$87.9M 0.01%
1,403,137
+179,495
+15% +$11.6M
SCHL icon
693
Scholastic
SCHL
$784M
$87.8M 0.01%
4,183,034
+1,021,995
+32% +$25M
MXL icon
694
MaxLinear
MXL
$6.95B
$87.7M 0.01%
3,772,006
-101,609
-3% -$2.51M
HLIT icon
695
Harmonic Inc
HLIT
$1.42B
$87.6M 0.01%
15,703,097
-257,238
-2% -$1.46M
UNF icon
696
Unifirst Corp
UNF
$5.21B
$87.5M 0.01%
461,959
+119,007
+35% +$22.3M
PRI icon
697
Primerica
PRI
$9.62B
$87.3M 0.01%
771,902
-36,386
-5% -$4.42M
HLI icon
698
Houlihan Lokey
HLI
$9.24B
$86.9M 0.01%
1,471,261
-5,338
-0.4% -$306K
AA icon
699
Alcoa
AA
$13.1B
$86.8M 0.01%
7,464,267
+1,213,904
+19% +$16.3M
KR icon
700
Kroger
KR
$35.1B
$86.1M 0.01%
2,540,477
-805,476
-24% -$27.8M

Similar funds

T. Rowe Price Associates's Q3 2020 Portfolio in Review

As of Q3 2020, T. Rowe Price Associates held 2,679 positions worth $864B, up 8.7% from $795B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q3 2020 filing shows 185 new, 873 increased, 1,330 reduced and 90 closed positions. Its largest new stake was nCino: 5,133,240 shares worth $395M. The largest sale was People Inc, an estimated $4.1B.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q3 2020 buy was nCino: 5,133,240 shares worth $395M.
  • T. Rowe Price Associates added most to Match Group in Q3 2020, an estimated $3.17B increase.
  • T. Rowe Price Associates's biggest Q3 2020 reduction was People Inc, cutting an estimated $4.1B.
  • T. Rowe Price Associates fully exited 58.com Inc in Q3 2020, selling an estimated $468M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $864B portfolio in Q3 2020.
  • T. Rowe Price Associates opened 185 new positions and closed 90 in Q3 2020.
  • T. Rowe Price Associates's portfolio value rose 8.7% quarter-over-quarter to $864B.

Based on T. Rowe Price Associates's 13F filing for Q3 2020, filed 16 Nov 2020.